Health Condition 1: E898- Other postprocedural endocrine andmetabolic complications and disorders
Conditions
Interventions
Intervention1: lifestyle and Oral contraceptive pills: lifestyle and dietary modification (32 ka cal/ kg diet/ day with 55 % carbohydrates, 20% protein, 20% fat and 20 grams fibre with 30 minutes bris
Sponsors
SKIMS
Eligibility
Inclusion criteria
Inclusion criteria: 1) Women aged 18-40 years. 2) Women permanent residents of that area ( >1 year). 3) Willingness to participate in the study and sign informed consent. 4) Women who are known to have PCOS not on treatment.
Exclusion criteria
Exclusion criteria: 1) Pregnant or lactating women and those with cognitive and/or physical limitations that prevented them from answering the questionnaire will be excluded from the study. 2) History of drug intake such as steroids, androgen, oral contraceptives, anti-epileptics or drugs known to interfere in glucose and lipid metabolism.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| a)Estimation of national prevalence, phenotypic variations and risk factors of PCOS in community. b)Quantitation of comorbidities among known cases of PCOS c)Comparison of the variation in efficacy of standard therapeutics modalities for metabolic dysfunction in PCOS women Timepoint: Baseline and follow up at the interval of 3 month and 6 month | — |
Secondary
| Measure | Time frame |
|---|---|
| a) Identification of prenatal/pre-pubertal factors including low birth weight, sexual precocity, pre-pubertal obesity, familial aggregation, maternal PCOS, GDM, antiepileptic drug, etc. contributing in the causation of PCOS. b) Assessment of knowledge and management practices among service providers in public health sector on PCOSTimepoint: Baseline, | — |
Countries
India
Contacts
Public ContactDr Mohd Ashraf Ganie
Sher-i-Kashmir Institute of Medical Sciences Soura, Srinagar
Outcome results
None listed